Supplementary Tables 1-3. from SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)